BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 29955847)

  • 1. Leptin Regulation of Cancer Stem Cells in Breast and Gynecologic Cancer.
    Crean-Tate KK; Reizes O
    Endocrinology; 2018 Aug; 159(8):3069-3080. PubMed ID: 29955847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and breast cancer: status of leptin and adiponectin in pathological processes.
    Grossmann ME; Ray A; Nkhata KJ; Malakhov DA; Rogozina OP; Dogan S; Cleary MP
    Cancer Metastasis Rev; 2010 Dec; 29(4):641-53. PubMed ID: 20821253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese women.
    Kato S; Abarzua-Catalan L; Trigo C; Delpiano A; Sanhueza C; García K; Ibañez C; Hormazábal K; Diaz D; Brañes J; Castellón E; Bravo E; Owen G; Cuello MA
    Oncotarget; 2015 Aug; 6(25):21100-19. PubMed ID: 26053184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of obesity and adipokines on breast and gynecologic malignancies.
    Tewari S; Vargas R; Reizes O
    Ann N Y Acad Sci; 2022 Dec; 1518(1):131-150. PubMed ID: 36302117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells: a novel mechanism for the obesity-breast cancer link.
    Zahid H; Subbaramaiah K; Iyengar NM; Zhou XK; Chen IC; Bhardwaj P; Gucalp A; Morrow M; Hudis CA; Dannenberg AJ; Brown KA
    Int J Obes (Lond); 2018 Apr; 42(4):711-720. PubMed ID: 29104286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and female malignancies.
    Benedetto C; Salvagno F; Canuto EM; Gennarelli G
    Best Pract Res Clin Obstet Gynaecol; 2015 May; 29(4):528-40. PubMed ID: 25779915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity-associated Breast Cancer: Analysis of risk factors.
    Engin A
    Adv Exp Med Biol; 2017; 960():571-606. PubMed ID: 28585217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin signals via TGFB1 to promote metastatic potential and stemness in breast cancer.
    Mishra AK; Parish CR; Wong ML; Licinio J; Blackburn AC
    PLoS One; 2017; 12(5):e0178454. PubMed ID: 28542577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
    Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
    JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer.
    Dignam JJ; Wieand K; Johnson KA; Fisher B; Xu L; Mamounas EP
    J Natl Cancer Inst; 2003 Oct; 95(19):1467-76. PubMed ID: 14519753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of obesity on the incidence and treatment of gynecologic cancers: a review.
    Modesitt SC; van Nagell JR
    Obstet Gynecol Surv; 2005 Oct; 60(10):683-92. PubMed ID: 16186785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Leptin: Involvement in the pathophysiology of breast cancer].
    Caldefie-Chézet F; Dubois V; Delort L; Rossary A; Vasson MP
    Ann Endocrinol (Paris); 2013 May; 74(2):90-101. PubMed ID: 23566612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritumoral expression of adipokines and fatty acids in breast cancer.
    Gnerlich JL; Yao KA; Fitchev PS; Goldschmidt RA; Bond MC; Cornwell M; Crawford SE
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S731-8. PubMed ID: 24052317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin-cytokine crosstalk in breast cancer.
    Newman G; Gonzalez-Perez RR
    Mol Cell Endocrinol; 2014 Jan; 382(1):570-582. PubMed ID: 23562747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India.
    Sultana R; Kataki AC; Borthakur BB; Basumatary TK; Bose S
    Gene; 2017 Jul; 621():51-58. PubMed ID: 28414093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells.
    Guo S; Liu M; Wang G; Torroella-Kouri M; Gonzalez-Perez RR
    Biochim Biophys Acta; 2012 Apr; 1825(2):207-22. PubMed ID: 22289780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer.
    Lipsey CC; Harbuzariu A; Daley-Brown D; Gonzalez-Perez RR
    World J Methodol; 2016 Mar; 6(1):43-55. PubMed ID: 27019796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity, adipocytokines, and insulin resistance in breast cancer.
    Rose DP; Komninou D; Stephenson GD
    Obes Rev; 2004 Aug; 5(3):153-65. PubMed ID: 15245384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin expression in breast nipple aspirate fluid (NAF) and serum is influenced by body mass index (BMI) but not by the presence of breast cancer.
    Sauter ER; Garofalo C; Hewett J; Hewett JE; Morelli C; Surmacz E
    Horm Metab Res; 2004 May; 36(5):336-40. PubMed ID: 15156414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Body mass index and cancer incidence:a prospective cohort study in northern China].
    Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.